Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis

Journal of Autoimmunity

Volumn 18, Issue 3, 2002, Pages 213-220

  Flynn, Jeffrey C ^a   Wan, Qiang ^a   Panos, John C ^b   McCormick, Daniel J ^c   Giraldo, Alvaro A ^b   David, Chella S ^c   Kong, Yi Chi M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Autoimmune thyroiditis; EAT; HLA DQ8; HLA DR3; NOD

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR3 ANTIGEN;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOWN REGULATION; EXPERIMENTAL TEST; HASHIMOTO DISEASE; HLA SYSTEM; HUMAN; MOLECULE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE;

EID: 0036591231     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0587     Document Type: Article

References (38)

1. Esquivel P.S., Rose N.R., Kong Y.M. Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J. Exp. Med. 145:1977;1250-1263.
2. Rose N.R., Twarog F.J., Crowle A.J. Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J. Immunol. 106:1971;698-704.
3. Beisel K.W., David C.S., Giraldo A.A., Kong Y.M., Rose N.R. Regulation of experimental autoimmune thyroiditis: mapping of susceptibility to the I-A subregion of the mouseH-2. Immunogenetics. 15:1982;427-431.
4. Kong Y.M., David C.S. New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models. Int. Rev. Immunol. 19:2000;573-585.
5. Wan Q., Shah R., Panos J.C., Giraldo A.A., David C.S., Kong Y.M. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Human Immunol. 63:2002;301-310.
6. Kong Y.M., David C.S., Lomo L.C., Fuller B.E., Motte R.W., Giraldo A.A. Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics. 46:1997;312-317.
7. Kong Y.M., Lomo L.C., Motte R.W., Giraldo A.A., Baisch J., Strauss G., Hämmerling G.J., David C.S. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med. 184:1996;1167-1172.
8. Marga M., Denisova A., Sochnev A., Pirags V., Farid N.R. Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. Am. J. Med. Genet. 102:2001;188-191.
9. Damotte D., Colomb E., Cailleau C., Brousse N., Charreire J., Carnaud C. Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis. Eur. J. Immunol. 27:1997;2854-2862.
10. + T cells are required for iodine accelerated thyroiditis in NOD mice. Cell. Immunol. 192:1999;113-121.
11. Many M.-C., Maniratunga S., Varis I., Dardenne M., Drexhage H.A., Denef J.-F. Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J. Endocrinol. 147:1995;311-320.
12. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:1995;179-200.
13. Leiter E.H. The NOD mouse meets the 'Nerup hypothesis': is diabetogenesis the result of a collection of common alleles present in unfavorable combinations? Shafrir E. Frontiers in Diabetes Research. Lessons From Animal Diabetes III. 1990;54-58 Smith-Gordon.
14. Kong Y.M., Giraldo A.A. Experimental autoimmune thyroiditis in the mouse and rat. Cohen I.R., Miller A. Autoimmune Disease Models: a Guidebook. 1994;123-145 Academic Press, Inc. San Diego.
15. Flynn J.C., Fuller B.E., Giraldo A.A., Panos J.C., David C.S., Kong Y.M. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice. J. Autoimmun. 17:2001;7-15.
16. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 66:1991;1051-1066.
17. Nabozny G.H., Baisch J.M., Cheng S., Cosgrove D., Griffiths M.M., Luthra H.S., David C.S. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:1996;27-37.
18. Abraham R.S., Wilson S.B., de Souza N.F. Jr, Strominger J.L., Munn S.R., David C.S. NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice. Human Immunol. 60:1999;583-590.
19. Grumet F.C., Charron D.J., Fendly B.M., Levy R., Ness D.B. HLA-DR epitope region definition by use of monoclonal antibody probes. J. Immunol. 125:1980;2785-2789.
20. Giles R.C., Nunez G., Hurley C.K., Nunez-Roldan A., Winchester R., Stastny P., Capra J.D. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J. Exp. Med. 157:1983;1461-1470.
21. Kong Y.M., David C.S., Giraldo A.A., ElRehewy M., Rose N.R. Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D -end genes. J. Immunol. 123:1979;15-18.
22. ElRehewy M., Kong Y.M., Giraldo A.A., Rose N.R. Syngeneic thyroglobulin is immunogenic in good responder mice. Eur. J. Immunol. 11:1981;146-151.
23. Kong Y.M. Experimental autoimmune thyroiditis in the mouse. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W. Current Protocols in Immunology. 1996;15.7.1-15.7.16 John Wiley & Sons, Inc. New York.
24. Kong Y.M., McCormick D.J., Wan Q., Motte R.W., Fuller B.E., Giraldo A.A., David C.S. Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis: secondary role of iodination. J. Immunol. 155:1995;5847-5854.
25. + cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis. Cell. Immunol. 122:1989;377-390.
26. Simon L.L., Justen J.M., Giraldo A.A., Krco C.J., Kong Y.M. Activation of cytotoxic T cells and effector cells in experimental autoimmune thyroiditis by shared determinants of mouse and human thyroglobulins. Clin. Immunol. Immunopathol. 39:1986;345-356.
27. + T-cell immune response. Immunol. Rev. 172:1999;335-343.
28. Kudva Y.C., Deng Y.-J., Govindarajan R., Abraham R.S., Marietta E.V., Notkins A.L., David C.S. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. Human Immunol. 62:2001;1099-1105.
29. Nabozny G.H., Simon L.L., Kong Y.M. Suppression in experimental autoimmune thyroiditis: the role of unique and shared determinants on mouse thyroglobulin in self-tolerance. Cell. Immunol. 131:1990;140-149.
30. Tomazic V., Rose N.R. Autoimmune murine thyroiditis. VIII. Role of different thyroid antigens in the induction of experimental autoimmune thyroiditis. Immunology. 30:1976;63-68.
31. Romball C.G., Weigle W.O. T cell competence to heterologous and homologous thyroglobulins during the induction of experimental autoimmune thyroiditis. Eur. J. Immunol. 14:1984;887-893.
32. Uno M., Miyazaki T., Uehira M., Nishimoto H., Kimoto M., Miyazaki J., Yamamura K. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules. Immunol. Lett. 31:1991;47-52.
33. k transgene in B10 mice suppresses the development of myasthenia gravis. Immunogenetics. 31:1990;241-244.
34. d transgene on collagen-induced arthritis. J. Exp. Med. 180:1994;1559-1564.
35. Wan Q., Shah R., McCormick D.J., Lomo L.C., Giraldo A.A., David C.S., Kong Y.M. H2-E transgenic class II-negative mice can distinguish self from nonself in susceptibility to heterologous thyroglobulins in autoimmune thyroiditis. Immunogenetics. 50:1999;22-30.
36. Strauss G., Vignali D.A.A., Schönrich G., Hämmerling G.J. Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice. Immunogenetics. 40:1994;104-108.
37. Hanson M.S., Cetkovic-Cvrlje M., Ramiya V.K., Atkinson M.A., Maclaren N.K., Singh B., Elliott J.F., Serreze D.V., Leiter E.H. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol. 157:1996;1279-1287.
38. Wen L., Chen N.-Y., Tang J., Sherwin R., Wong F.S. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J. Clin. Invest. 107:2001;871-880.